News & Media

Stay in the know
News

First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

16 January 2023

Precision Cancer Medicine thematic member, Dr Yong Wei Peng was part of a team who developed an antibody-drug conjugate ...

Read More →
Research News

Mitochondria transfer mediates stress erythropoiesis

21 December 2022

Mitochondria are specialised compartments of the cell that function as powerhouses by playing a crucial role in metaboli...

Read More →
Research News

Colorectal cancer surveillance in the community

21 December 2022

Early-stage colorectal cancer (CRC) patients are recommended to get a review every 3-6 months for 5 years after operatio...

Read More →
Research News

Personalised therapy for relapsed/refractory lymphoma

21 December 2022

Non-Hodgkin’s lymphoma is a common form of blood cancer with a high proportion of patients either developing treatment...

Read More →
News

Hope for blood cancer patients with new stem cell technique

20 December 2022

A/Prof Koh Liang Piu, member of the N2CR Tissue-Specific Carcinogenesis theme, helped to develop a cell selection techni...

Read More →
News

ST Singaporean of the Year nominee: A/Prof Too Heng-Phon

20 December 2022

(image credit: The Straits Times)   For the past two decades, Prof Too has played a tremendous role in strengthenin...

Read More →
News

Clarivate Highly Cited Researchers 2022 – Dr Alan Prem Kumar

19 December 2022

Every year, analytics company Clarivate publishes a list of highly cited researchers who have constantly produced high i...

Read More →
News

N2CR members named in Top 2% of Scientists Cited Worldwide

7 December 2022

Every year Stanford University publishes a list of highly cited scientists based on citation metrics from Scopus. The li...

Read More →
News

MiRXES creates world’s first blood test to detect gastric cancer

30 November 2022

N2CR member Associate Professor Too Heng-Phon, who co-foundered biotech firm MiRXES with two of his former PhD students,...

Read More →